TY - JOUR
T1 - X-linked inheritance of Fanconi anemia complementation group B
AU - Meetei, Amom Ruhikanta
AU - Levitus, Marieke
AU - Xue, Yutong
AU - Medhurst, Annette L.
AU - Zwaan, Michel
AU - Ling, Chen
AU - Rooimans, Martin A.
AU - Bier, Patrick
AU - Hoatlin, Maureen
AU - Pals, Gerard
AU - De Winter, Johan P.
AU - Wang, Weidong
AU - Joenje, Hans
N1 - Funding Information:
D. Schlessinger for critically reading the manuscript and the National Cell Culture Center for providing cells. Financial support was from the Dutch Cancer Society, The Netherlands Organization for Health Research and Development, the FA Research Fund Inc., the Ellison medical Foundation, the US National Institutes of Health and the Deutsche FA Hilfe e.V.
PY - 2004/11
Y1 - 2004/11
N2 - Fanconi anemia is an autosomal recessive syndrome characterized by diverse clinical symptoms, hypersensitivity to DNA crosslinking agents, chromosomal instability and susceptibility to cancer. Fanconi anemia has at least 11 complementation groups (A, B, C, D1, D2, E, F, G, I, J, L); the genes mutated in 8 of these have been identified. The gene BRCA2 was suggested to underlie complementation group B, but the evidence is inconclusive. Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA. Unexpectedly, the gene encoding this protein, FANCB, is localized at Xp22.31 and subject to X-chromosome inactivation. X-linked inheritance has important consequences for genetic counseling of families with Fanconi anemia belonging to complementation group B. Its presence as a single active copy and essentiality for a functional Fanconi anemia-BRCA pathway make FANCB a potentially vulnerable component of the cellular machinery that maintains genomic integrity.
AB - Fanconi anemia is an autosomal recessive syndrome characterized by diverse clinical symptoms, hypersensitivity to DNA crosslinking agents, chromosomal instability and susceptibility to cancer. Fanconi anemia has at least 11 complementation groups (A, B, C, D1, D2, E, F, G, I, J, L); the genes mutated in 8 of these have been identified. The gene BRCA2 was suggested to underlie complementation group B, but the evidence is inconclusive. Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA. Unexpectedly, the gene encoding this protein, FANCB, is localized at Xp22.31 and subject to X-chromosome inactivation. X-linked inheritance has important consequences for genetic counseling of families with Fanconi anemia belonging to complementation group B. Its presence as a single active copy and essentiality for a functional Fanconi anemia-BRCA pathway make FANCB a potentially vulnerable component of the cellular machinery that maintains genomic integrity.
UR - http://www.scopus.com/inward/record.url?scp=10944239213&partnerID=8YFLogxK
U2 - 10.1038/ng1458
DO - 10.1038/ng1458
M3 - Article
C2 - 15502827
AN - SCOPUS:10944239213
SN - 1061-4036
VL - 36
SP - 1219
EP - 1224
JO - Nature Genetics
JF - Nature Genetics
IS - 11
ER -